The role of the patient in maximizing efficacy of drug therapy in migraine

Disease Management and Health Outcomes

Volumn 9, Issue 4, 2001, Pages 187-201

  Pryse Phillips, W ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIMIGRAINE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; GABAPENTIN; LAMOTRIGINE; PROPRANOLOL; VALPROIC ACID; VERAPAMIL;

BEHAVIOR THERAPY; DIET; FAMILY; HUMAN; LIFESTYLE; MIGRAINE; PATIENT ATTITUDE; PATIENT CARE; PATIENT COMPLIANCE; PRIMARY MEDICAL CARE; QUALITY OF LIFE; REVIEW; SELF HELP; SIDE EFFECT; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 0035048377     PISSN: 11738790     EISSN: None     Source Type: Journal    
DOI: 10.2165/00115677-200109040-00002     Document Type: Review

References (56)

1. Shifting the focus from migraine attacks to migraineurs
2. The impact of drug therapy on quality of life in headache and migraine
3. Impact of migraine and tension-type headache on life-style, consulting behaviour and medication use: A Canadian population study
4. A Canadian population study on the clinical, epidemiologic and societal impact of migraine and tension-type headache
5. American migraine study II: Prevalence, burden and health care utilization for migraine in the United States
6. The impact of migraine on quality of life in the general population. The GEM study
7. Measuring the functional status and well-being of patients with migraine headache
8. The migraine ACE model: Evaluating the impact of time lost and medical resource
9. A study of migraine and its effects in a working population
10. Impact of headache on sickness absence and utilisation of medical services: A Danish population study
11. Migraine: Identifying and removing barriers to care
12. Migraine symptoms: Results of a survey of self-reported migraineurs
13. Migraine headache: Epidemiology and health care utilization
14. Undiagnosed migraine headaches. A comparison of symptom-based and physician diagnosis
15. Guidelines for the diagnosis and management of migraine in clinical practice
16. Sumatriptan for the range of high migraine sufferers: Results of the spectrum study
17. Pilot study to improve health outcomes for medication-induced headache sufferers
18. Prescribing practices for the management of headache in Newfoundland and Labrador
19. Survey of migraineurs referred to headache specialists: Care, satisfaction and outcomes
20. Medical consultation for migraine: Results from the American Migraine Study
21. The UK migraine patient survey: Quality of life and treatment
22. Acute migraine therapy: Do doctors understand what patients with migraine want from therapy?
23. Sumatriptan treatment of migraine in a health maintenance porganization: Economic, humanistic and clinnical outcomes
24. Usding pre-treatment quality of life perceptions to predict response to sumatriptan in migraineurs
25. A multinational investigation of the impact of subcutaneous sumatriptan. II. Health related quality of life
26. A multinational investigation of the impact of subcutaneous sumatriptan. III. Workplace productivity
27. Improvements in health-related quality of life with sumatriptan treatment for migraine
28. Impact of sumatriptan on workplace productivity, nonwork activities and health related quality of life among hospital employees with migraine
29. Migraine: Diagnosis and assessment of disability
30. Medication use and disability among migraineurs: A national probability sample survey
31. Suffering in silence
32. Patients with primary headache disorders in the emergency department
33. Sumatriptan nonresponders: A survey in 366 migraine patients
34. Effect of early intervention with sumatripan on migraine pain: Retrospective analyses of data from three clinical trials
35. Prevention of migraine during prodrome with naratriptan
36. Emerging nonspecific migraine therapies: Targets and unmet needs
37. The use of exercise as a method of aborting migraine
38. Problems and needs of frequent migraine sufferers: A focus group study
39. Guidelines for the nonpharmacologic management of migraine in clinical practice
40. Dietary therapy of vascular headaches
41. Assessment of dietary risk factors in ahronic headache
42. Repetitive intravenous DHE in the treatment of refractory headaches
43. Characteristics of dependent and non-dependent regular users of codeine
44. New guidelines for barbiturate-containing analgesics: Don't start and help stop!
45. How to assess patient preference of migraine treatments
46. Treatment of mild headache in disabled migraine sufferers: Results of the spectrum study
47. Interventions and outcomes management in migraine
48. The use of antidepressants in the treatment of chronic pain
49. Introduction of a novel self-injector for sumatriptan: A controlled clinical trial in general practice
50. If migraine prophylaxis does not work, think about compliance
51. Noncompliance may render migraine prophylaxis useless but once-daily regimens are better
52. Patient education and migraine: A pilot study
53. Compliance with drug therapy by epileptic patients
54. Analgesic use: A study of treatments used by patients for migraine prior to attending the City of London Migraine Clinic